Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Acetamidoacrylic acid, also known as N-acetyl-L-glutamic acid, is an organic compound with the chemical formula C5H9NO3. It is a white to off-white powder and is a derivative of acrylic acid with an amide group attached to the 2nd carbon. 2-Acetamidoacrylic acid is known for its versatile chemical properties and potential applications in various industries.

5429-56-1 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 5429-56-1 Structure
  • Basic information

    1. Product Name: 2-Acetamidoacrylic acid
    2. Synonyms: 2-AcetaMidoacrylic acid, 99+% 5GR;N-Acetyl-α-aMinoacrylic Acid;NSC 14171;2-Propenoic acid,2-(acetylaMino)-;2-Acetamidoacrylic acid, N-Acetamidoacrylic acid;Acetyl-dehydro-Alanine≥ 99% (Titration);N-ACETYLDEHYDROALANINE;ACETYL-DEHYDROALANINE
    3. CAS NO:5429-56-1
    4. Molecular Formula: C5H7NO3
    5. Molecular Weight: 129.11
    6. EINECS: 226-583-3
    7. Product Categories: amino;monomer;Amino Acids & Derivatives
    8. Mol File: 5429-56-1.mol
    9. Article Data: 9
  • Chemical Properties

    1. Melting Point: 185-186 °C (dec.)(lit.)
    2. Boiling Point: 239.15°C (rough estimate)
    3. Flash Point: 206.9 °C
    4. Appearance: white to off-white powder
    5. Density: 1.3816 (rough estimate)
    6. Vapor Pressure: 3.56E-08mmHg at 25°C
    7. Refractive Index: 1.4220 (estimate)
    8. Storage Temp.: Refrigerator
    9. Solubility: DMSO (Slightly), Methanol (Slightly)
    10. PKA: 3.53±0.11(Predicted)
    11. Water Solubility: hardly soluble
    12. BRN: 1812032
    13. CAS DataBase Reference: 2-Acetamidoacrylic acid(CAS DataBase Reference)
    14. NIST Chemistry Reference: 2-Acetamidoacrylic acid(5429-56-1)
    15. EPA Substance Registry System: 2-Acetamidoacrylic acid(5429-56-1)
  • Safety Data

    1. Hazard Codes: Xi
    2. Statements: 36/37/38
    3. Safety Statements: 26-36-37/39
    4. WGK Germany: 3
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 5429-56-1(Hazardous Substances Data)

5429-56-1 Usage

Uses

Used in Pharmaceutical Industry:
2-Acetamidoacrylic acid is used as an intermediate in the synthesis of various pharmaceutical compounds, particularly those related to the treatment of neurological disorders. Its unique structure allows for the development of novel drugs with improved efficacy and reduced side effects.
Used in Antioxidant Applications:
2-Acetamidoacrylic acid is used as an antioxidant in the food and cosmetic industries. Its ability to neutralize free radicals and prevent oxidative damage makes it a valuable additive for preserving the quality and shelf life of products.
Used in Polymer Industry:
2-Acetamidoacrylic acid is used as a monomer in the production of polymers with specific properties, such as enhanced strength, flexibility, and resistance to environmental factors. These polymers can be utilized in a wide range of applications, including automotive, electronics, and packaging materials.
Used in Research and Development:
2-Acetamidoacrylic acid is used as a research compound for studying its chemical properties and potential applications in various fields. Its unique structure and reactivity make it an interesting subject for scientific investigation and the development of new technologies.

Check Digit Verification of cas no

The CAS Registry Mumber 5429-56-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,2 and 9 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 5429-56:
(6*5)+(5*4)+(4*2)+(3*9)+(2*5)+(1*6)=101
101 % 10 = 1
So 5429-56-1 is a valid CAS Registry Number.
InChI:InChI=1/C5H7NO3/c1-3(5(8)9)6-4(2)7/h1H2,2H3,(H,6,7)(H,8,9)/p-1

5429-56-1 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • TCI America

  • (A1443)  2-Acetamidoacrylic Acid  >98.0%(T)

  • 5429-56-1

  • 5g

  • 780.00CNY

  • Detail
  • Alfa Aesar

  • (L01649)  2-Acetamidoacrylic acid, 99%   

  • 5429-56-1

  • 1g

  • 378.0CNY

  • Detail
  • Alfa Aesar

  • (L01649)  2-Acetamidoacrylic acid, 99%   

  • 5429-56-1

  • 5g

  • 654.0CNY

  • Detail
  • Alfa Aesar

  • (L01649)  2-Acetamidoacrylic acid, 99%   

  • 5429-56-1

  • 25g

  • 2781.0CNY

  • Detail

5429-56-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Acetamidoacrylic acid

1.2 Other means of identification

Product number -
Other names 2-acetamidoprop-2-enoic acid

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5429-56-1 SDS

5429-56-1Relevant articles and documents

Boron Accumulation in Brain Tumor Cells through Boc-Protected Tryptophan as a Carrier for Boron Neutron Capture Therapy

Chio, Chun-Ming,Chou, You-Cheng,Hsu, Fu-Chun,Huang, Ying-Cheng,Lai, Yen-Buo,Yu, Chung-Shan

supporting information, p. 589 - 596 (2020/04/30)

Boron neutron capture therapy (BNCT) is a binary therapeutic approach. Nonradioactive boron-10 atoms accumulated in tumor cells combining with the neutron beams produce two highly energetic particles that could eradicate the cell that takes it and the neighboring cells. Small molecules that carry boron atom, e.g. 5- and 6-boronated and 2,7-diboronated tryptophans, were assessed for their boron accumulation in U87-MG, LN229, and 3T3 for BNCT. TriBoc tryptophan, TB-6-BT, shows boron-10 at 300 ppm in both types of tumor cells with a tumor to normal ratio (T/N) of 5.19-5.25 (4 h). TB-5-BT and DBA-5-BT show boron-10 at 300 ppm (2 h) in U87-MG cells. TB-5-BT exerts a T/N of >9.66 (1 h) in LN229 compared with the current clinical boronophenyl alanine with a highest T/N of 2.3 (1 h) and accumulation concentration of 50 ppm. TB-5-BT and TB-6-BT warrant further animal study.

Tailored Approaches towards the Synthesis of l-S-(Trifluoromethyl)cysteine- and l-Trifluoromethionine-Containing Peptides

Gadais, Charlène,Saraiva-Rosa, Nathalie,Chelain, Evelyne,Pytkowicz, Julien,Brigaud, Thierry

supporting information, p. 246 - 251 (2017/01/24)

Among the fluorinated noncanonical amino acids, l-trifluoromethionine (TFM) and l-S-(trifluoromethyl)cysteine (TfmCys), fluorinated analogues of methionine and cysteine, are of particular interest because of their ability to locally increase the hydrophobicity of peptides. We report herein the synthesis of tert-butoxycarbonyl/benzyl-protected TFM and TfmCys by using a cheap and user-friendly radical trifluoromethylation approach. The benzyl protecting group of these fluorinated amino acids could be conveniently removed by hydrogenolysis, which circumvented troublesome saponification reactions. For the first time, TfmCys was inserted into a peptide sequence by liquid- or solid-phase peptide synthesis. Finally, a late trifluoromethylation strategy with the use of Togni's reagent on disulfide-bridged peptides was also efficient to incorporate TFM or TfmCys at both N-terminal and internal positions.

Synthesizing method using serine to prepare Ramipril key intermediate

-

Paragraph 0077; 0078, (2016/10/10)

The invention relates to a synthesizing method using serine to prepare a Ramipril key intermediate. The Ramipril key intermediate is 2-azabicyclo[3.3.0] octane-3-carboxylic acid hydrochloride or benzyl ester hydrochloride. The synthesizing method includes: using the serine as the initial raw material, and sequentially performing esterification, acyl chloride acylation, deacidification, Michael addition, hydrolysis and hydrogenation reduction to obtain the Ramipril key intermediate. The synthesizing method has the advantages that the key intermediate is synthesized by a five-step method, and the synthesizing method is cheap in raw material, environmentally friendly, simple in preparation process, simple to operate, mild in reaction condition, short in reaction cycle, convenient in post-treatment, low in equipment requirement, capable of avoiding heavy metal pollution and the use of expensive catalysts, few in three wastes, high in product yield and purity and suitable for industrial production.

First RAFT polymerization of captodative 2-acetamidoacrylic acid (AAA) monomer: An experimental and theoretical study

Dedeo?lu, Burcu,U?ur, Ilke,De?irmenci, Isa,Aviyente, Viktorya,Bar?in, Bilin?,?ayli, G?khan,Acar, Havva Yagci

, p. 5122 - 5132 (2013/09/02)

A capto-dative monomer, 2-acetamidoacrylic acid (AAA), was homopolymerized through RAFT polymerization method using 2-(2-cyanopropanyl dithiobenzoate) (CPDB) as a chain transfer agent and AIBN free radical initiator in DMF at 70 C. DFT calculations were performed in the selection of the CTA for this unique monomer as well as to elucidate the influence of cd-stabilized growing radical on the kinetic parameters in comparison to methacrylic acid (MAA) and N-(prop-1-en-2-yl)acetamide (NPAA), which represent the captive and dative groups of AAA, respectively. Keq for these three monomers is in the order of AAA β > k-add for NPAA and MAA, for AAA k-add is about four orders of magnitude larger than kβ. This is the major disadvantage in the RAFT process of AAA using CPDB. Yet, poly(AAA) could be achieved with PDI as low as 1.49. Molecular weight of the polymer can be tuned by the monomer/AIBN ratio. First block copolymers of AAA with MAA and MMA using poly(AAA) as a macro-CTA were also synthesized, indicating the presence of active chain ends.

Stable triazolylphosphonate analogues of phosphohistidine

Mukai, Shin,Flematti, Gavin R.,Byrne, Lindsay T.,Besant, Paul G.,Attwood, Paul V.,Piggott, Matthew J.

, p. 857 - 874 (2012/10/07)

Histidine-phosphorylated proteins and the corresponding kinases are important components of bacterial and eukaryotic cell-signalling pathways, and are therefore potential drug targets. The study of these biomolecules has been hampered by the lability of the phosphoramidate functional group in the phosphohistidines and the lack of generic antibodies. Herein, the design and concise synthesis of stable triazolylphosphonate analogues of N1-and N3-phosphohistidine, and derivatives suitable for bioconjugation, are described. Springer-Verlag 2011.

The facile synthesis of a series of tryptophan derivatives

Blaser, Georg,Sanderson, John M.,Batsanov, Andrei S.,Howard, Judith A.K.

, p. 2795 - 2798 (2008/09/19)

This study reports a facile method for the synthesis of a variety of 5- and 6-substituted tryptophan derivatives that are difficult to prepare using alternative enzymatic approaches. Acylation of an activated amino acid, derived from serine in situ, is coupled with an enzymatic resolution step to furnish enantiopure analogues bearing a range of electron withdrawing and releasing substituents. Isolation of a dehydroalanine derivative as a by-product from some reactions provides some insights into the likely mechanism of the reaction.

Syntheses without protection: A three-step synthesis of optically active clavicipitic acid by utilizing biomimetic synthesis of 4-bromotryptophan

Yokoyama, Yuusaku,Hikawa, Hidemasa,Mitsuhashi, Masaharu,Uyama, Aki,Murakami, Yasuoki

, p. 7803 - 7806 (2007/10/03)

The optically active clavicipitic acid (4), an ergot alkaloid, was synthesized by a three-step sequence from 4-bromoindole (1). The reaction of 1 with dl-serine (2) in the presence of Ac2O followed by enzymatic kinetic resolution gave (S)-4-bromotryptophan (3). The Heck reaction of 3 with 1,1-dimethylallylalcohol in aqueous media gave clavicipitic acid in one-pot.

A Useful and Biomimetic Synthesis of N-Acyl α,β-Dehydroalanine form Aspartic Acid

Seki, Masahiko,Moriya, Tamon,Matsumoto, Kazuo

, p. 1251 - 1256 (2007/10/02)

N-Acyl α,β-dehydroalanines (1) were synthesized from the corresponding N-acyl aspartic acids by a one-pot procedure through a biomimetic oxidative β-decarboxylation.In particular, the transformation using methanol-sodium hypochlorite aqueous solution, which served for N-chlorination and dehydrochlorination, afforded good yields of (1).

Metal phosphine complex

-

, (2008/06/13)

Group IB and IIB metal phosphine complexes are disclosed. These complexes are reacted with rhodium complex precursors to form useful enantioselective hydrogenation catalysts. Also disclosed is a method of preparing useful compounds having optical activity such as natural products and compounds useful as flavors and fragrances.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 5429-56-1